Rosiglitazone therapy associated with increased risk for heart attack: Study
Links shared publicly online about this topic.
- 1,059total visits
Rosiglitazone therapy associated with increased risk for heart attack: Study
View full resource at news-medical.net
Tags: Heart, Heart Disease, Heart Attack, Diabetes Type 2 Medication, Diabetes Medication, Avandia, Avandamet, Avandaryl
Most Recently Shared on June 29, 2010 at 12:04 pm By:
Rosiglitazone therapy associated with increased risk for heart attack: Study: Eleven years after the introduction ... http://bit.ly/9zOoQx
Long-term exposure to estrogen increases high blood pressure in women
news-medical.net — “For many years doctors believed the estrogen women consumed in the form of oral contraceptives and hormone replacement therapy pills was good for their patients' hearts. Recent studies however have shown that long-term exposure to estrogen can be a danger to women as it has been associated with high blood pressure, a key link to heart- and brain-attacks.” View full resource at news-medical.net
Most Recently Shared on May 27, 2011 at 5:22 am By:
Long-term exposure to estrogen increases high blood pressure in women: For many years doctors believed the estro... http://bit.ly/lSHxWF
Health care system delay may increase risk of death for heart patients receiving reperfusion therapy
physorg.com — “For patients with a certain type of heart attack, delay in the time between first contact with emergency medical service to initiation of therapy such as balloon angioplasty is associated with an increased risk of death, according to a study in the August 18 issue of JAMA.” View full resource at physorg.com
Most Recently Shared on August 17, 2010 at 8:40 pm By:
PhysOrg Health News Health News
Health care system delay may increase risk of death for heart patients receiving reperfusion therapy http://tw.physorg.com/201281428
Diabetes Drug Rosiglitazone Not Associated With Increased Risk Of Death, Stroke Or Heart Attacks In BARI 2D Study
medicalnewstoday.com — “Rosiglitazone, a commonly used diabetes drug, poses no significant increased risk of death, stroke or heart attack, though it does increase the risk of fractures, according to a new analysis of th” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2010 at 12:36 pm By:
MNT Cardiovascular Health News
Diabetes Drug Rosiglitazone Not Associated With Increased Risk Of Death, Stroke Or Heart Attacks In BARI 2D Study http://mnt.to/3Fvq
Advertisement
